Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice
- 31 October 2008
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 129 (1) , 49-57
- https://doi.org/10.1016/j.clim.2008.06.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Enhanced thymic selection of FoxP3 + regulatory T cells in the NOD mouse model of autoimmune diabetesProceedings of the National Academy of Sciences, 2007
- Plasmid-based gene therapy of diabetes mellitusGene Therapy, 2007
- Gene-based vaccines: recent technical and clinical advancesTrends in Molecular Medicine, 2006
- Gene-Gun Biolistic Immunization Encoding Glutamic Acid Decarboxylase: A Model for Studying Langerhans Cell Abnormalities and Mimicry in the Nonobese Diabetic MouseAnnals of the New York Academy of Sciences, 2005
- Intradermal or Oral Delivery of GAD-Encoding Genetic Vaccines Suppresses Type 1 DiabetesDNA and Cell Biology, 2003
- Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safetyEuropean Journal of Immunology, 2001
- Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome DegradationJournal of Virology, 2001
- Biolistic-Mediated Interleukin 4 Gene Transfer Prevents the Onset of Type 1 DiabetesHuman Gene Therapy, 2000
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987